AT-1/SLC33A1 mutations and gene duplication events that disrupt ER acetylation are linked to severe phenotypes, including developmental delay with childhood death, peripheral neuropathy, and dysmorphism with autism spectrum disorder and intellectual disability4,14–19. This evidence concerns the gene SLC33A1 and peripheral neuropathy.